Quantessence Capital Portfolio holdings
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$28.6M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$12.7M |
| 3 |
Pfizer
PFE
|
+$11M |
| 4 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$10.2M |
| 5 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$9.88M |
Top Sells
| 1 |
International Paper
IP
|
+$11.1M |
| 2 |
iShares US Real Estate ETF
IYR
|
+$11.1M |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.23M |
| 4 |
UMB Financial
UMBF
|
+$6.83M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$6.69M |
Sector Composition
| 1 | Healthcare | 24.24% |
| 2 | Financials | 15.91% |
| 3 | Technology | 11.39% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Staples | 7.93% |
Similar funds
Quantessence Capital's Q1 2025 Portfolio in Review
As of Q1 2025, Quantessence Capital held 490 positions worth $400M, up 64% from $244M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Quantessence Capital deployed $166M of net new capital in Q1 2025, opening 266 new positions and adding to 41 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 229,788 shares worth $30.3M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 5.7% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares US Real Estate ETF, an estimated $11.1M trimmed.
- Quantessence Capital's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 229,788 shares worth $30.3M.
- Quantessence Capital added most to Beacon Roofing Supply, Inc. in Q1 2025, an estimated $9.88M increase.
- Quantessence Capital's biggest Q1 2025 reduction was iShares US Real Estate ETF, cutting an estimated $11.1M.
- Quantessence Capital fully exited International Paper in Q1 2025, selling an estimated $11.1M.
- Quantessence Capital's ten largest holdings make up 29% of its $400M portfolio in Q1 2025.
- Quantessence Capital opened 266 new positions and closed 158 in Q1 2025.
- Quantessence Capital's portfolio value rose 64% quarter-over-quarter to $400M.
Based on Quantessence Capital's 13F filing for Q1 2025, filed 15 May 2025.